Professor, Radiation Oncology, Medical College of Wisconsin
Radiation Oncology
Dr. Roger W. Byhardt, MD
|
|
Give Review
Doctor Roger W. Byhardt, MD works in the field of Radiation Oncology. He attended Medical College of Wisconsin. Medical College of Wisconsin has a rank of 54 in research and a 62 in primary care He received awards:"Super Doctor". Roger Byhardt is also a published doctor. He has 14 paper published. The most recent paper is: Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
Publications
- Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
- The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies.
- Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
- The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
- MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
- Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an a...
- Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC).
- Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Onco...
- Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology...
- Do "elderly fit" patients have less comorbidity?
- Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated o...
- Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread t...
- Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
Schools
Medical College of Wisconsin
St Joseph Hospital
Penrose Cancer Hospital
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
Awards
- Super Doctor
Education
-
Exempla St Joseph Hospital -
Medical College of Wisconsin
Hospital
-
Froedtert Memorial Lutheran Hospital
Helpful Reviews
Similar Doctors
|
Dr. Ranjini B. Gandhavadi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Glenn L. Applegate, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Malika L. Siker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Perry M. Gould, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura B. Ulmer, MD |